cyc 202 has been researched along with THZ531 in 2 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (THZ531) | Trials (THZ531) | Recent Studies (post-2010) (THZ531) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 19 | 0 | 18 |
| Protein | Taxonomy | cyc 202 (IC50) | THZ531 (IC50) |
|---|---|---|---|
| Cyclin-T1 | Homo sapiens (human) | 0.5135 | |
| Cyclin-K | Homo sapiens (human) | 0.2656 | |
| Cyclin-A2 | Homo sapiens (human) | 1.3 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 1.3 | |
| Cyclin-dependent kinase 7 | Homo sapiens (human) | 4.4025 | |
| Cyclin-dependent kinase 9 | Homo sapiens (human) | 0.5135 | |
| Cyclin-H | Homo sapiens (human) | 5.8173 | |
| CDK-activating kinase assembly factor MAT1 | Homo sapiens (human) | 8.5 | |
| Cyclin-dependent kinase 13 | Homo sapiens (human) | 0.265 | |
| Cyclin-dependent kinase 12 | Homo sapiens (human) | 2.3247 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Dios, A; Lallena, MJ; Sánchez-Martínez, C; Sanfeliciano, SG | 1 |
| Diab, S; Wang, S; Yu, M | 1 |
2 review(s) available for cyc 202 and THZ531
| Article | Year |
|---|---|
Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015-2019).
Topics: Aminopyridines; Animals; Antineoplastic Agents; Benzimidazoles; Breast Neoplasms; Cell Cycle Checkpoints; Cyclin-Dependent Kinases; Drug Discovery; Humans; Indoles; Piperazines; Protein Kinase Inhibitors; Purines; Pyridines; Pyrimidines; Transcription Factors | 2019 |
CDK7 Inhibitors in Cancer Therapy: The Sweet Smell of Success?
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; Humans; Neoplasms; Protein Kinase Inhibitors | 2020 |